The Food and Drug Administration

Drug ads to get more FDA scrutiny USA Today Mon, 25 Feb 2008 9:20 AM PST The Food and Drug Administration's current budget for reviewing consumer drug advertisements is larger than in the previous five years combined.

Avastin approval lifts Genentech shares CNN Money Mon, 25 Feb 2008 9:54 AM PST The company's stock surges 9.6% after the Food and Drug Administration clears the biotech's breast cancer drug.

Grassplot-brand pachyrhizus is recalled UPI Mon, 25 Feb 2008 8:15 AM PST The U.S. Food and Drug Administration announced the nationwide recall of Grassplot-brand dried pachyrhizus because it contains undeclared sulfites.

Firms to stop making false medical claims UPI Mon, 25 Feb 2008 6:30 AM PST The U.S. Food and Drug Administration said two companies have agreed to stop making claims their products can cure, treat, mitigate or prevent diseases.

Boston Scientific Gets 3 FDA Approvals AP via Yahoo! Finance Mon, 25 Feb 2008 6:52 AM PST Medical device maker Boston Scientific Corp. said Monday the U.S. Food and Drug Administration granted approval for three of its heart-related products: Confient, Livian and upgraded Latitude.

Ahead of the Bell: Genentech Rises AP via Yahoo! Finance Mon, 25 Feb 2008 5:33 AM PST Genentech Inc. shares rose in premarket trading Monday after the Food and Drug Administration approved Genentech's drug Avastin to treat metastasized breast cancer.

Genentech Shares Jump on FDA Avastin Nod AP via Yahoo! Finance Mon, 25 Feb 2008 8:15 AM PST Shares of Genentech Inc. jumped Monday following Friday's announcement that the company's best-selling drug, Avastin, received Food and Drug Administration approval as a breast cancer treatment.

Drug stocks climb; Genentech jumps on Avastin okay Market Watch Mon, 25 Feb 2008 8:14 AM PST BOSTON (MarketWatch) -- Genentech Inc. led drug stocks higher early Monday, with shares of the biotech giant jumping on Friday's news that the Food and Drug Administration has granted conditional approval for its oncology drug Avastin for the treatment of advanced breast cancer.

Genentech rockets on FDA approval for Avastin Market Watch Mon, 25 Feb 2008 10:11 AM PST Shares of Genentech Inc. soar on news that the Food and Drug Administration has approved its oncology drug Avastin for treating advanced breast cancer, opening up a promising additional market for the drug.

FDA gets tough on rogue health claims Nutraingredients.com Mon, 25 Feb 2008 9:38 AM PST The Food and Drug Administration said both Cherry Capital Services and Brownwood Acres Foods have a history of promoting unapproved claims, such as " chemicals found in cherries may help fight diabetes."